Evidence map›Paper›PMID 38238235›Full record

Observational studyThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2024

The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease.

Christopher B Morrow, Jared T Hinkle, Joseph Seemiller, Kelly A Mills, Gregory M Pontone

Open access · greenAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Behavioral disorders in Parkinson disease: current view.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christopher B MorrowDepartment of Psychiatry and Behavioral Sciences (CBM, JTH, GMP), Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: cmorrow3@jhmi.edu.
Jared T HinkleDepartment of Psychiatry and Behavioral Sciences (CBM, JTH, GMP), Johns Hopkins University School of Medicine, Baltimore, MD.
Joseph SeemillerDepartment of Neurology (JS, KAM), Johns Hopkins University School of Medicine, Baltimore, MD.
Kelly A MillsDepartment of Neurology (JS, KAM), Johns Hopkins University School of Medicine, Baltimore, MD.
Gregory M PontoneDepartment of Psychiatry and Behavioral Sciences (CBM, JTH, GMP), Johns Hopkins University School of Medicine, Baltimore, MD; Department of Neurology (GMP), University of Florida College of Medicine, Gainesville, FL.
Johns Hopkins University · US

Funding

Johns Hopkins Center of Excellence in Regulatory Science and Innovation (JH-CERSI)U01FD005942 · FDA · JOHNS HOPKINS UNIVERSITY · PI ALEXANDER, G. CALEB · 2016 to 2025
$15.5M
Institutional Career Development CoreKL2TR003099 · NCATS · JOHNS HOPKINS UNIVERSITY · PI GEBO, KELLY A · 2019 to 2023
$7.9M
Visual hallucinations and memory impairment in Parkinson's Disease: The role of hippocampal networksR01MH123552 · NIMH · JOHNS HOPKINS UNIVERSITY · PI BAKKER, ARNOLD, PONTONE, GREGORY MICHAEL · 2021 to 2025
$3.1M
Molecular Imaging of the Nicotinic Cholinergic Receptor in Parkinson's disease (PD): Implication of for understanding the neurobiology of cognitive impairmentK23NS101096 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MILLS, KELLY ALEXANDER · 2017 to 2021
$1000k
The role of cortical nicotinic receptors in pathological brain oscillations in Parkinson's disease cognitive impairmentR21NS128391 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MILLS, KELLY ALEXANDER · 2023 to 2024
$450k
FDA HHS U01 FD005942NCATS NIH HHS KL2 TR003099NIA NIH HHS L30 AG083912NIMH NIH HHS R01 MH123552NINDS NIH HHS K23 NS101096NINDS NIH HHS R21 NS128391
6 · The paper itself

Abstract

objectivesTo examine whether initiation of an antidepressant is associated with the development of impulse control disorder (ICD) in patients with Parkinson's disease (PD).

designWe performed a retrospective analysis utilizing data from the Parkinson's Progression Markers Initiative (PPMI). Two-sample Mann-Whitney tests were used for comparison of continuous variables and Pearson χ

settingThe PPMI is a multicenter observational study of early PD with 52 sites throughout North America, Europe, and Africa.

participantsParticipants in the current study were those in the PPMI PD cohort with a primary diagnosis of idiopathic PD. MEASUREMENTS: The presence of ICD was captured using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP). Antidepressant use was defined based on medication logs for each participant. Depressive symptoms were captured using the Geriatric Depression Scale (GDS).

resultsA total of 1,045 individuals were included in the final analysis. There was a significant increase in the probability of ICD in those exposed to serotonergic antidepressants compared to those not exposed (Log-rank p <0.001). Serotonergic antidepressant use was associated with a hazard ratio for ICD of 1.4 (95% CI 1.0-1.8, z-value 2.1, p = 0.04) after adjusting for dopamine agonist use, depression, bupropion use, MAOI-B use, amantadine use, LEDD, disease duration, sex, and age.

conclusionsSerotonergic antidepressant use appears to be temporally associated with ICD in patients with PD.

Indexed as

Antidepressive AgentsDisruptive, Impulse Control, and Conduct DisordersParkinson DiseaseAgedDepressionFemaleHumansMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesAntidepressive Agentsantidepressantsdepressionimpulse control disordernonmotor symptomsParkinson's disease

Identifiers

PMID38238235
PMCPMC11096064
OpenAlexW4390570353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.